ArticleQuality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation2020

FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease.

Bellinda L King-Kallimanis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.